Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 13 publications
Belumosudil Demonstrates Steroid-Sparing, Safety and Efficacy in Pediatric Chronic Graft Versus Host Disease.
Journal: Transplantation and cellular therapy
Published: February 20, 2026
Emergence and Implications of DNMT3A Mutations in Pediatric AML Post-HSCT: A Case Report and Literature Review.
Journal: Pediatric blood & cancer
Published: June 04, 2025
Blinatumomab overcomes poor prognostic impact of measurable residual disease in pediatric high-risk first relapse B-cell precursor acute lymphoblastic leukemia.
Journal: Pediatric blood & cancer
Published: October 25, 2021
Safety and Efficacy of Blinatumomab in Japanese Adult and Pediatric Patients with Relapsed/Refractory B-Cell Precursor Acute Lymphoblastic Leukemia: Final Results from an Expansion Cohort.
Journal: Acta haematologica
Published: July 20, 2021
Efficacy and safety of blinatumomab: Post hoc pooled analysis in Asian adults with relapsed/refractory B-cell precursor acute lymphoblastic leukemia.
Journal: Asia-Pacific journal of clinical oncology
Published: March 19, 2021
Long-term follow-up of blinatumomab in patients with relapsed/refractory Philadelphia chromosome-positive B-cell precursor acute lymphoblastic leukaemia: Final analysis of ALCANTARA study.
Journal: European journal of cancer (Oxford, England : 1990)
Published: August 24, 2020
Paediatric Strategy Forum for medicinal product development for acute myeloid leukaemia in children and adolescents: ACCELERATE in collaboration with the European Medicines Agency with participation of the Food and Drug Administration.
Journal: European journal of cancer (Oxford, England : 1990)
Published: April 24, 2020
A phase 1b study of blinatumomab in Japanese children with relapsed/refractory B-cell precursor acute lymphoblastic leukemia.
Journal: International journal of hematology
Published: August 13, 2019
Last Updated: 09/26/2026